Skip to content

Medical Grand Rounds: Safe Voting in a Pandemic: Challenges, Innovations and the Role of Health Care Professionals

In This Article

  • On October 15, 2020, the Department of Medicine at Massachusetts General Hospital co-hosted a virtual Grand Rounds presentation related to COVID-19 with Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center
  • Charles Stewart III, Kenan Sahin distinguished professor of Political Science at Massachusetts Institute of Technology, presented to the Boston medical community about about safe voting during a pandemic

In a virtual Medical Grand Rounds co-hosted by Massachusetts General Hospital, Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center on October 15, 2020, Charles Stewart III, Kenan Sahin distinguished professor of Political Science at Massachusetts Institute of Technology, spoke to the Boston medical communityabout safe voting during a pandemic.

The session was moderated by Katrina Armstong, MD, physician-in-chief in the Department of Medicine at Mass General. A panel made up of medical residents followed that included:

  • Sejal Hathi, MD, MBA, and Radhika Jain, MD, of the Department of Medicine at Massachusetts General Hospital 
  • Audrey Li, MD, and Debanjan Pain, MD, Beth Israel Deaconess Medical Center 
  • Jessica Stuart, MD, and Kelly Schuering, MD, Brigham and Women’s Hospital 
  • Jonathan Kusner, Harvard Medical School

Watch the video »

View all COVID-19 updates

Learn about COVID-19 Grand Rounds at Mass General

Related topics

Related

On September 10, 2020, the Department of Medicine held a virtual Grand Rounds on COVID-19. Anthony S. Fauci, MD, National Institute of Allergy and Infectious Diseases (NIAID) director, spoke to the Boston medical community about COVID-19 public health and scientific challenges.

Related

Since the initial outbreak of COVID-19, clinicians have treated hundreds of thousands of patients. At the same time, over 55,000 COVID-related research articles have been published (albeit of heterogeneous quality). There is now substantial consensus on optimal treatment of the critically ill patient with COVID-19.